Skip to main content
OpenTrials

Clinical trial condition

Urinary Incontinence

Explore clinical trials studying Urinary Incontinence. Study availability and eligibility vary by location and protocol.

721 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Urinary Incontinence trial results

Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

NCT02216214

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Site US00066 Huntsville, Alabama, United States
  • Site US00148 Mobile, Alabama, United States
  • Site US00009 Anchorage, Alaska, United States
  • Site US00020 Tucson, Arizona, United States
View all 120 locations
View Trial Details
Completed

A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00912964

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Chandler, Arizona, United States
View all 151 locations
View Trial Details
Completed

A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy

NCT01371994

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Urological Associates of Southern Arizona Tucson, Arizona, United States
  • University of California, San Diego Moores Cancer Center La Jolla, California, United States
View all 60 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.

NCT01638000

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Site: 37406 Yerevan, Armenia
  • Site: 37404 Yerevan, Armenia
  • Site: 37403 Yerevan, Armenia
  • Site: 37401 Yerevan, Armenia
View all 217 locations
View Trial Details
Completed

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00688688

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Montgomery, Alabama, United States
View all 308 locations
View Trial Details
Completed

A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00662909

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Montgomery, Alabama, United States
View all 125 locations
View Trial Details

Related conditions